Dose-finding and pharmacokinetic study of ABT-510 with gemcitabine and cisplatin in patients with advanced cancer

被引:0
|
作者
De Vos, FY
Hoekstra, R
Eskens, FALM
De Vries, EG
Van der Gaast, A
Groen, HJM
Knight, R
Humerickhouse, RA
Gietema, JA
Verweij, J
机构
[1] Univ Groningen Hosp, Groningen, Netherlands
[2] Twenteborg Hosp, Almelo, Netherlands
[3] Erasmus Med Ctr, Rotterdam, Netherlands
[4] Abbott Labs, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3077
引用
收藏
页码:214S / 214S
页数:1
相关论文
共 50 条
  • [1] Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors
    Kuenen, BC
    Rosen, L
    Smit, EF
    Parson, MRN
    Levi, M
    Ruijter, R
    Huisman, H
    Kedde, MA
    Noordhuis, P
    van der Vijgh, WJF
    Peters, GJ
    Cropp, GF
    Scigalla, P
    Hoekman, K
    Pinedo, HM
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1657 - 1667
  • [2] Cisplatin-gemcitabine-paclitaxel in advanced nonsmall cell lung cancer (NSCLC). A dose-finding study
    Comella, P
    Frasci, G
    Panza, N
    Pacilio, C
    Nicolella, GP
    Natale, M
    Manzione, L
    Gravina, A
    Cioffi, R
    Maiorino, L
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 98 - 98
  • [3] Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer
    Hoekstra, R
    de Vos, FYFL
    Eskens, FALM
    Gietema, JA
    van der Gaast, A
    Groen, HJM
    Knight, RA
    Carr, RA
    Humerickhouse, RA
    Verweij, J
    de Vries, EGE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5188 - 5197
  • [4] A phase I dose escalating study of the angiogenesis inhibitor thrombospondin-1 mimetic (ABT-510) in patients with advanced cancer
    de Vos, FYFL
    Hoekstra, R
    Gietema, JA
    Jager, PJ
    Eskens, FALM
    Carr, R
    Guirguis, M
    Humerickhouse, R
    de Vries, EGE
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S78 - S79
  • [5] Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer
    Fizazi, K
    Ducreux, M
    Ruffié, P
    Bonnay, M
    Daniel, C
    Soria, JC
    Hill, C
    Fandi, A
    Poterre, M
    Smith, M
    Armand, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) : 2293 - 2300
  • [6] A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer
    Seiji Yoshitomi
    Naruto Taira
    Hiroyoshi Doihara
    Taeko Mizoo
    Tomohiro Nogami
    Takayuki Iwamoto
    Takayuki Motoki
    Tadahiko Shien
    Yutaka Ogasawara
    Junji Matsuoka
    Hisashi Tsuji
    Toshiharu Mitsuhashi
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 289 - 294
  • [7] A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer
    Yoshitomi, Seiji
    Taira, Naruto
    Doihara, Hiroyoshi
    Mizoo, Taeko
    Nogami, Tomohiro
    Iwamoto, Takayuki
    Motoki, Takayuki
    Shien, Tadahiko
    Ogasawara, Yutaka
    Matsuoka, Junji
    Tsuji, Hisashi
    Mitsuhashi, Toshiharu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 289 - 294
  • [8] Pharmacokinetic and dose-finding study in cancer patients with impaired renal function
    Fujiwara, Y.
    Makihara, R.
    Sakiyama, N.
    Makino, Y.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S1289 - S1289
  • [9] Marimastat in patients with advanced pancreatic cancer - A dose-finding study
    Rosemurgy, A
    Harris, J
    Langleben, A
    Casper, E
    Goode, S
    Rasmussen, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (03): : 247 - 252
  • [10] A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors
    Uronis, H. E.
    Bendell, J.
    Blobe, G.
    Morse, M.
    Geier, D.
    Nixon, A.
    Howard, L.
    Evans, D.
    Li, H.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)